Evidence Level
Red Raspberry Leaf is an herbal remedy commonly used during pregnancy, though its clinical evidence base remains limited. Simpson et al. (2001) conducted a double-blind, randomized, placebo-controlled trial involving 192 low-risk first-time mothers. Participants received either 2 x 1.2g raspberry leaf tablets or placebo from 32 weeks gestation. The study found that the treatment group experienced a statistically significant reduction in the second stage of labor (mean 9.59 minutes shorter) and a lower rate of forceps delivery (19.3% vs. 30.4%) compared to the placebo group. Both groups reported no adverse effects on maternal or neonatal outcomes.
An earlier retrospective observational study by Parsons et al. (1999) involving 108 mothers at Westmead Hospital also found that raspberry leaf consumption during pregnancy was associated with shorter labor duration and reduced need for interventions such as cesarean sections, without any adverse effects. These findings align with the results of Simpson et al. (2001), suggesting potential benefits of raspberry leaf in improving labor outcomes.
Despite these encouraging results, the evidence base remains limited by the small sample size of the 1999 study and the need for larger, multi-center trials to confirm these findings definitively. Further research is required to establish the efficacy and safety of raspberry leaf as a routine intervention during pregnancy.